Surgery Websites
LiverSource »  Faculty »  Gastroenterology »  Jonathan P. Terdiman, M.D.
Jonathan P. Terdiman, M.D.

Jonathan P. Terdiman, M.D.

Professor of Clinical Medicine and Surgery
Chief, Clinical Gastroenterology
Associate Director, Colitis and Crohn's Disease Center
Director, Hereditary Gastrointestinal Cancer Prevention Program

Contact Information

Academic Office
Division of Gastroenterology
2330 Post Street, Suite 610
San Francisco, CA 94115
Phone: (415) 353-7906
Fax: 415-502-2249
Gastroenterology at Mount Zion
2330 Post St., Suite 610
San Francisco, CA 94115
Phone: (415) 502-4444
Fax: (415) 502-2249
Hours: Monday to Friday
9 a.m. - 4:30 p.m.
Inflammatory Bowel Disease Center
2330 Post St., Sixth Floor
San Francisco, CA 94115
Phone: (415) 502-4444
Fax: (415) 502-2249

Cancer Risk Program
1600 Divisadero St., Second Floor
San Francisco, CA 94143-1714
Phone: (415) 885-7779
Open Popup
  • 1981-85 College, Princeton University, A.B., cum laude
  • 1985-89 Medical School, Columbia University, College of Physicians and Surgeons, M.D
  • 1989-1990 Internship, Internal Medicine, University of California, San Francisco
  • 1990-1992 Residency, Internal Medicine, University of California, San Francisco
  • 1992-1993 Fellowship, Critical Care Medicine, University of California, San Francisco
  • 1993-1996 Fellowship, Gastroenterology, University of California, San Francisc
  • American Board of Internal Medicine, Diplomate in Internal Medicine
  • American Board of Internal Medicine, Diplomate in Gastroenterology
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • Division of Colorectal Surgery, Department of Surgery
  • Gastrointestinal Cancer Prevention Program
  • Colitis and Crohn's Disease Center
  • Acute Pancreatitis
  • Cholangiocarcinoma
  • Chronic Pancreatitis
  • Cirrhosis
  • Colon Cancer
  • Constipation
  • Crohns Disease
  • Gallstones
  • Gastroparesis
  • Heartburn
  • Inflammatory bowel disease
  • Pancreatic Cancer
  • Primary Sclerosing Cholangitis
  • Rectal Cancer
  • Ulcerative Colitis
  • Ulcers
  • Colorectal cancer prevention and risk identification
  • Prognostic and predictive biomarkers in IBD

Jonathan Terdiman, M.D. is co-director of the Center for Inflammatory Bowel Disease and the Colorectal Cancer Prevention Program at UCSF Medical Center. His research interests include colorectal cancer prevention, hereditary gastrointestinal cancer and inflammatory bowel disease. He frequently lectures in the community, at the university and for various professional organizations on these subjects.

Terdiman earned a medical degree at Columbia University, College of Physicians and Surgeons. He went on to complete a residency in internal medicine and fellowships in critical care medicine and gastroenterology at UCSF where he is a professor of clinical medicine and surgery.

Dr. Terdiman's research interests are related to clinical and translational research in the areas of colorectal cancer prevention, especially among individuals at high risk for cancer, such as those with hereditary cancer syndromes or those with longstanding inflammatory bowel disease. Particular areas of interest include the optimal provision of genetic counseling and testing, cancer risk factor
identification and risk mitigation by interventions such as drugs (chemoprevention) and colonoscopy. 

Dr. Terdiman also studies the use of genetic and genomic markers to determine cancer risk and prognosis and prediction of response to therapy among those already diagnosed with cancer. He also is interested in projects related to biomarkers of prognosis and prediction of response to therapies in patients with inflammatory bowel disease.

Most recent publications from a total of 104
  1. Selvig D, Piceno Y, Terdiman J, Zydek M, Umetsu SE, Balitzer D, Fadrosh D, Lynch K, Lamere B, Leith T, Kassam Z, Beck K, Lewin S, Ma A, Somsouk M, Lynch SV, El-Nachef N. Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study. Dig Dis Sci. 2019 Jul 13. View in PubMed
  2. Gutin L, Piceno Y, Fadrosh D, Lynch K, Zydek M, Kassam Z, LaMere B, Terdiman J, Ma A, Somsouk M, Lynch S, El-Nachef N. Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile. United European Gastroenterol J. 2019 Jul; 7(6):807-814. View in PubMed
  3. Adler E, Tabaa A, Kassam Z, Zydek M, Terdiman J, El-Nachef N. Capsule-Delivered Fecal Microbiota Transplant Is Safe and Well Tolerated in Patients with Ulcerative Colitis. Dig Dis Sci. 2019 Mar 27. View in PubMed
  4. Mao EJ, Lewin S, Terdiman JP, Beck K. Safety of dual biological therapy in Crohn's disease: a case series of vedolizumab in combination with other biologics. BMJ Open Gastroenterol. 2018; 5(1):e000243. View in PubMed
  5. Kidambi TD, Terdiman JP, Lee JK. Negative withdrawal time: simple and efficient. Gastrointest Endosc. 2018 10; 88(4):781. View in PubMed
  6. Kidambi TD, Terdiman JP, El-Nachef N, Singh A, Kattah MG, Lee JK. Effect of I-scan Electronic Chromoendoscopy on Detection of Adenomas During Colonoscopy. Clin Gastroenterol Hepatol. 2019 Mar; 17(4):701-708.e1. View in PubMed
  7. Kidambi TD, Goldberg D, Nussbaum R, Blanco A, Umetsu SE, Terdiman JP, Lee JK. Novel variant of unknown significance in MUTYH in a patient with MUTYH-associated polyposis: a case to reclassify. Clin J Gastroenterol. 2018 Dec; 11(6):457-460. View in PubMed
  8. Gray PN, Tsai P, Chen D, Wu S, Hoo J, Mu W, Li B, Vuong H, Lu HM, Batth N, Willett S, Uyeda L, Shah S, Gau CL, Umali M, Espenschied C, Janicek M, Brown S, Margileth D, Dobrea L, Wagman L, Rana H, Hall MJ, Ross T, Terdiman J, Cullinane C, Ries S, Totten E, Elliott AM. TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome. Oncotarget. 2018 Apr 17; 9(29):20304-20322. View in PubMed
  9. Kidambi TD, Pedley C, Blanco A, Bergsland EK, Terdiman JP. Lower gastrointestinal neuroendocrine neoplasms associated with hereditary cancer syndromes: a case series. Fam Cancer. 2017 10; 16(4):537-543. View in PubMed
  10. Kidambi TD, Schmajuk G, Gross AJ, Ostroff JW, Terdiman JP, Lee JK. Endoscopy is of low yield in the identification of gastrointestinal neoplasia in patients with dermatomyositis: A cross-sectional study. World J Gastroenterol. 2017 Jul 14; 23(26):4788-4795. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Jonathan P. Terdiman, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.


Site Directory